Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Randomized Controlled Trial

Clinical Trial, Phase I

Clinical Trial

Multicenter Study

Clinical Trial, Phase II

Clinical Trial, Phase III

Publication Year

From

Quick links

Individual year

2024

2018

2017

2016

2015

2014

2012

2005

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Opsonin Proteins""[mesh_terms]

10 Results

Searching titles within these results

Effect of glutamine supplementation on neutrophil function in male judoists.

Shigeyuki Nakaji, Takashi Umeda, Ippei Takahashi, Erika Hashizume, Eiji Sasaki, Kojima Arata, Yousuke Yamamoto, Masaru Tanabe, Kazuyuki Oyamada

Luminescence : the journal of biological and chemical luminescence 2014;28(4):442-9

Full Text

Abstract

Opsonization-independent antigen-specific recognition by myeloid phagocytes expressing monoclonal antibodies.

Michael Neumaier, Sophie Giesler, Volker Ast, Mathis Roemer, Timo-Daniel Voß, Eileen Reinz, Victor Costina, Martin Schmelz, Elina Nürnberg, Stefanie Nittka, Aino-Maija Leppä, Ruediger Rudolf, Andreas Trumpp, Tina Fuchs

Science advances 2024;9(35):eadg1812

Free Full Text

Abstract

Open-label trial of immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults ≥ 50 years of age in Mexico.

Juan Carlos Tinoco, Christine Juergens, Guillermo M Ruiz Palacios, Jorge Vazquez-Narvaez, Hermann Leo Enkerlin-Pauwells, Vani Sundaraiyer, Sudam Pathirana, Elena Kalinina, William C Gruber, Daniel A Scott, Beate Schmoele-Thoma

Clinical and vaccine immunology : CVI 2015;22(2):185-92

Free Full Text

Abstract

Functional activity of antibodies after immunization of Finnish and Israeli infants with an 11-valent pneumococcal conjugate vaccine.

Tomi K Wuorimaa, Ron Dagan, Fabrice Bailleux, Raili Haikala, Nina Ekström, Juhani Eskola, Mansour Yaich, Helena Käyhty

Vaccine 2005;23(46-47):5328-32

Full Text

Abstract

Effect of opsonophagocytosis mediated by specific antibodies on the co-amoxiclav serum bactericidal activity against Streptococcus pneumoniae after administration of a single oral dose of pharmacokinetically enhanced 2000/125 mg co-amoxiclav to healthy volunteers.

Luis Alou, Lorenzo Aguilar, David Sevillano, María-José Giménez, Beatriz Laguna, Olatz Echeverría, Antonio Carcas, Rubin Lubomirov, Julio Casal, José Prieto

The Journal of antimicrobial chemotherapy 2005;55(5):742-7

Full Text

Abstract

Factor H binding proteins protect division septa on encapsulated Streptococcus pneumoniae against complement C3b deposition and amplification.

Anuj Pathak, Jan Bergstrand, Vicky Sender, Laura Spelmink, Marie-Stephanie Aschtgen, Sandra Muschiol, Jerker Widengren, Birgitta Henriques-Normark

Nature communications 2018;9(1):3398

Free Full Text

Abstract

Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study.

Robert W Frenck, C Buddy Creech, Eric A Sheldon, David J Seiden, Martin K Kankam, James Baber, Edward Zito, Robin Hubler, Joseph Eiden, Joseph M Severs, Shite Sebastian, Jasdeep Nanra, Kathrin U Jansen, William C Gruber, Annaliesa S Anderson, Douglas Girgenti

Vaccine 2017;35(2):375-384

Free Full Text

Abstract

Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trial.

Eric A Sheldon, David J Seiden, Martin K Kankam, James Baber, C Buddy Creech, Robert W Frenck, Edward T Zito, Douglas Girgenti, Joseph M Severs, Frederick W Immermann, Lisa K McNeil, David Cooper, Kathrin U Jansen, William Gruber, Joseph Eiden, Annaliesa S Anderson

Vaccine 2017;35(2):385-394

Free Full Text

Abstract

Immunogenicity, reactogenicity and safety of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Mexican infants.

Guillermo M Ruiz-Palacios, M Lourdes Guerrero, Lorena Hernández-Delgado, Antonio Lavalle-Villalobos, Abigail Casas-Muñoz, Yolanda Cervantes-Apolinar, Marta Moreira, Lode Schuerman

Human vaccines 2012;7(11):1137-45

Full Text

Abstract

Anti-CD20 Therapy Acts via FcγRIIIA to Diminish Responsiveness of Human Natural Killer Cells.

Cristina Capuano, Maddalena Romanelli, Chiara Pighi, Giuseppe Cimino, Angela Rago, Rosa Molfetta, Rossella Paolini, Angela Santoni, Ricciarda Galandrini

Cancer research 2016;75(19):4097-108

Full Text

Abstract

Results: 1 – 10 / 10

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Opsonin Proteins""[mesh_terms]

Effect of glutamine supplementation on neutrophil function in male judoists.

Opsonization-independent antigen-specific recognition by myeloid phagocytes expressing monoclonal antibodies.

Open-label trial of immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults ≥ 50 years of age in Mexico.

Functional activity of antibodies after immunization of Finnish and Israeli infants with an 11-valent pneumococcal conjugate vaccine.

Effect of opsonophagocytosis mediated by specific antibodies on the co-amoxiclav serum bactericidal activity against Streptococcus pneumoniae after administration of a single oral dose of pharmacokinetically enhanced 2000/125 mg co-amoxiclav to healthy volunteers.

Factor H binding proteins protect division septa on encapsulated Streptococcus pneumoniae against complement C3b deposition and amplification.

Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study.

Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trial.

Immunogenicity, reactogenicity and safety of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Mexican infants.

Anti-CD20 Therapy Acts via FcγRIIIA to Diminish Responsiveness of Human Natural Killer Cells.

Results for
""Opsonin Proteins""[mesh_terms]